Similar to what we observed for TES alone (Fig. 2B), spleen M-MDSCs treated with GM-CSF alone had a significant shift toward PMN-MDSC–like cells (15%) whereas tumor M-MDSCs did not respond to this stimulus (1.5%) (Fig. 2B). The gene discussed is CSF2; the disease is neoplasm.